In the summer of 2025, the latest data of the World Meteorological Organization shows that the global average temperature is 1.3 ℃ higher than that before industrialization, and the abnormal climate leads to a 23% year-on-year increase in the incidence rate of respiratory diseases. In this context, CareAge Compressor Nebulizer reconstructs home respiratory care standards with six core technologies, providing a comprehensive solution from treatment to prevention for families worldwide.
1. Respiratory Health Alert under Climate Crisis
Due to the dual impact of extreme weather and air pollution, the number of pneumonia patients shows a bimodal trend of "younger age+older age". Traditional inhalation administration has problems such as low particle deposition rate and serious drug waste, while CareAge Compressor Nebulize breaks through the bottleneck of home use in medical grade nursing:
2.2 micron sized mist particle diameter (MMAD) increases direct alveolar deposition rate by 40%, effectively covering both pediatric bronchioles and elderly atrophied alveoli
The golden ratio of ≤ 5 μ m mist particles with a proportion greater than 75% has been verified by Swiss medical laboratories, and its therapeutic effect is 1.8 times higher than that of conventional equipment
2. Redefine the six dimensions of CareAge Compressor Nebulize
Ultra fine atomization system
Using military grade piezoelectric ceramic plates, the drug solution is decomposed into 2.2 micron sized particles (equivalent to one-third of the diameter of red blood cells), breaking through the bronchial ciliary barrier and directly reaching the lesion.
Efficient drug conversion
By using vortex separation technology to achieve a drug utilization rate of 78%, compared to the 50% residual liquid volume of traditional nebulizers, a single treatment of CareAge Compressor Nebulize can save about $1.2 in drug costs (calculated based on the average price of asthma medication in the United States)
Precise dose control
The patented metering valve ensures a residual liquid volume of less than 0.2mL, CareAge Compressor Nebulize is especially suitable for expensive biologics such as monoclonal antibody nebulization solutions
Industrial grade durability design
The aluminum magnesium alloy inner frame of CareAge Compressor Nebulize has passed a 300 hour salt spray test, with no inner tube structure to prevent bacterial growth. The continuous working noise is only 45dB (equivalent to the sound of light rain)
Multi scenario adaptation technology
The exclusive "lying flat atomizer cup" of Nebulizer Inhaler has obtained FDA Class II certification and supports administration at any angle from 0-90 degrees. It can be operated by breastfeeding mothers and bedridden patients
24/7 security protection
IP21 protection level of Nebulizer Inhaler can resist accidental splashes, with built-in temperature sensors for real-time monitoring of core component status
3. Nebulizer Inhaler's Health Evidence in London Families
The respiratory department of a hospital in London, UK, tracked 30 asthma families using Nebulizer Inhaler (2024/07-2025/07):
The number of emergency visits has decreased by 67%
Nighttime symptom frequency reduced by 54%
92% of users stated that 'device operation time is shorter than preparing a cup of coffee'
4. Why does every family need Nebulizer Inhaler?
Preventive care: Three minutes of physiological saline nebulization daily can enhance respiratory mucosal defense
Economic calculation: Compared to frequent outpatient nebulization, the equipment of Nebulizer Inhaler cost can be recovered in 6 months
Emergency value: When sudden wheezing occurs, using Nebulizer Inhaler 15 minutes is equivalent to the pre emergency room treatment effect
Visit www.careagehc.com now to learn about the health choices of 2 million households worldwide, and follow our Facebook https://www.facebook.com/CareAgeLift/ for the 'Respiratory Care Guidelines for Climate Sensitive People'. Make CareAge Nebulizer Inhaler the 'respiratory health gatekeeper' of your home.